Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β₂-adrenergic polymorphisms^*

References

• Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study. Am J Respir Crit Care Med 2004;170:836-44
   PubMed Web of Science ®Google Scholar
• Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bulletin 2000;56:1054-70
   PubMed Web of Science ®Google Scholar
• Palmer LJ, Silverman ES, Weiss ST, et al. Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002;165:861-6
   PubMed Web of Science ®Google Scholar
• Taylor DR, Kennedy MA. Beta-adrenergic receptor polymorphisms and drug responses in asthma. Pharmacogenomics 2002;3:173-84
   PubMed Web of Science ®Google Scholar
• Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-9
   PubMed Web of Science ®Google Scholar
• Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Nat Acad Sci 2000;97:10483-8
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Weiss ST. The pharmacogenetics of asthma: an update. Cur Opin Mol Ther 2005;7:209-17
   PubMed Web of Science ®Google Scholar
• Liggett SB. Beta2-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 2000;161:S197-201
   PubMed Web of Science ®Google Scholar
• Hawkins GA, Tantisira K, Meyers DA, et al. Sequence, haplotype, and association analysis of ADRB2 in a multiethnic asthma case–control study. Am J Respir Crit Care Med 2006;174:1101-9
   PubMed Web of Science ®Google Scholar
• Taylor DR, Epton MJ, Kennedy MA, et al. Bronchodilator response in relation to adrenoceptor haplotype in patients with asthma. Am J Respir Crit Care Med 2005;172:700-3
   PubMed Web of Science ®Google Scholar
• Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-8
   PubMed Web of Science ®Google Scholar
• Lipworth BJ, Hall IP, Aziz I, et al. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. Clin Sci 1999;96:253-9
   PubMed Web of Science ®Google Scholar
• Tan S, Hall IP, Dewar J, et al. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997;350:995-9
   PubMed Web of Science ®Google Scholar
• Joos L, Sandford AJ. Genotype predictors of response to asthma medications. Cur Opin Pulm Med 2002;8:9-15
   PubMed Web of Science ®Google Scholar
• Dewar JC, Hall IP. Personalised prescribing for asthma: is pharmacogenetics the answer? J Pharm Pharmacol 2003;55:279-89
   PubMed Web of Science ®Google Scholar
• Green SA, Turki J, Innis M, et al. Amino-terminal polymorphisms of the human b2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochem 1994;33:9414-9
   PubMed Web of Science ®Google Scholar
• Green SA, Turki J, Bejarano P, et al. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995;13:25-33
   PubMed Web of Science ®Google Scholar
• Green SA, Cole G, Jacinto M, et al. A polymorphism of the human b2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993;268:23116-21
   PubMed Web of Science ®Google Scholar
• Green SA, Rathz DA, Schuster AJ, et al. The Ile164 b2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs. Eur J Pharmacol 2001;421:141-7
   PubMed Web of Science ®Google Scholar
• Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-12
   PubMed Web of Science ®Google Scholar
• Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the beta2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80
   PubMed Web of Science ®Google Scholar
• Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-5
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Lehman E, Lazarus SC, et al. Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173:519-26
   PubMed Web of Science ®Google Scholar
• Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term beta agonist use: influence of beta2 adrenoceptor polymorphism. Thorax 2000;55:762-7
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Yancey SW, Baitinger LA, et al. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol 2006;18:809-16
   Google Scholar
• Bleecker ER, Postma DS, Lawrence RM, et al. Effect of ADRB2 polymorphisms on response to long-acting ß2-agonists therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007;370:2118-25
   PubMed Web of Science ®Google Scholar
• Nelson HS, Wolfe JD, Gross G, et al. Efficacy and safety of fluticasone propionate 44 mcg/salmeterol 21 mcg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy Asthma Immunol 2003;91:263-9
   PubMed Web of Science ®Google Scholar
• Pearlman D, Peden D, Condemi J, et al. Efficacy and safety of fluticasone propionate/salmeterol HFA 134a MDI in patients with mild to moderate persistent asthma. J Asthma 2004;41:797-806
   PubMed Web of Science ®Google Scholar
• Nathan RA, Rooklin A, Schoaf L, et al. Efficacy and tolerability of cluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescents and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Clin Ther 2006;28:73-85
   PubMed Web of Science ®Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44
   PubMed Web of Science ®Google Scholar
• Liggett SB. Polymorphisms of the beta2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156:S156-62
   PubMed Web of Science ®Google Scholar
• Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 1993;21:3761-6
   PubMed Web of Science ®Google Scholar
• Dempster AP, Laird NM, Rubin DB. Maximum-likelihood from incomplete data via the EM alogorithm. J Royal Stat Soc B 1977;39:1-38
   Google Scholar
• Anderson GP. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. Am J Respir Crit Care Med 2000;161:S188
   PubMed Web of Science ®Google Scholar
• Ferdinands JM, Mannino DM, Gwinn ML, et al. ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality; Results from the Atherosclerosis Risk in communities Study 2007 PLoS ONE 3: e389
   Google Scholar
• Tsai HJ, Kho JY, Shaikh N, et al. Admixture-matched case-control study: a practical approach for genetic association studies admixed populations. Hum Genet 2006;118:626-39
   PubMed Web of Science ®Google Scholar
• Choundhry S, Coyle NE, Tang H, et al. Population stratification confounds genetic association studies among Latinos. Hum Genet 2006;118:652-64
   PubMed Web of Science ®Google Scholar
• Wenzel S, Balzar S, Ampleford E, et al. IL-4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 2007;175:570-6
   PubMed Web of Science ®Google Scholar
• Cho S-H, Oh SY, Bahn JW, et al. Association between bronchodilating response to short-acting B-agonist and non-synonymous single-nucleotide polymorphisms of B2-adrenoceptor gene. Clin Exp Allergy 2005;35:1162-7
   PubMed Web of Science ®Google Scholar